The Indian pharmaceutical sector can be seen developing at a tremendous pace and creating a powerful impact on the global landscape. Indian organizations, to take a leap forward and explore the international markets, will essentially have to undergo a business model transformation and shift their focus towards innovation led growth. That is what we are attempting to do here at Gnosis. Gnosis of tomorrow shall enjoy a wider global spectrum with better penetration in the sphere of pharmaceuticals and biotechnology. At the same time, we will continue to strengthen our pipeline and widen sales prospect by investing significantly in product innovation. Doing this shall build on our ability to develop niche products at affordable prices and remain sustainable in domestic and international markets. Capitalizing on our core strengths, we are well-placed to create a strong footprint in the emerging pharmaceutical markets in Asia, Africa and Latin America.